Keyphrases
Clinical Significance
100%
Molecular Targets
100%
Radioiodine Therapy
100%
Endocytic Pathway
100%
Human Sodium Iodide Symporter (hNIS)
100%
Adaptor Protein 2
100%
Plasma Membrane
50%
Chloroquine
50%
Endocytosis
50%
Differentiated Thyroid Cancer
50%
Radioiodide Uptake
50%
Radioiodide
50%
FDA-approved Drugs
50%
C-terminus
25%
Poor Prognosis
25%
Disease-free Survival
25%
Mechanistic Understanding
25%
Patient Outcomes
25%
Oncogene
25%
Ill-defined
25%
Histone Deacetylase Inhibitor (HDACi)
25%
Mutagenesis
25%
Clinical Prognosis
25%
Interaction Assay
25%
Balb C Mice
25%
Risk Score
25%
Bioinformatics Analysis
25%
Dipeptide
25%
Cell Surface Biotinylation
25%
Biotinylation Assay
25%
Recurrence Prediction
25%
Druggability
25%
Plasma Membrane Targeting
25%
Aggressive Thyroid Cancer
25%
Heterotetramer
25%
Drug Modulation
25%
NanoBiT
25%
99mTc-pertechnetate
25%
NanoBRET
25%
Biochemistry, Genetics and Molecular Biology
Cell Membrane
100%
Sodium-Iodide Symporter
100%
C-Terminus
66%
Endocytosis
66%
Internalization
66%
Messenger RNA
33%
Histone Deacetylase
33%
Mutagenesis
33%
Disease Free Survival
33%
Proto Oncogene
33%
Bagg Albino Mouse
33%
Cell Assay
33%
Dipeptide
33%
Biotinylation
33%
Heterotetramer
33%
Bioinformatics
33%
Medicine and Dentistry
Radioactive Iodine
100%
Sodium Iodide Symporter
100%
Adaptor Protein
66%
Cell Membrane
50%
Carboxy Terminal Sequence
33%
Differentiated Thyroid Cancer
33%
Endocytosis
33%
Internalization
33%
Chloroquine
33%
Cell Surface
16%
Disease Free Survival
16%
Recurrent Disease
16%
Messenger RNA
16%
Thyroid Cancer
16%
Proto Oncogene
16%
Technetium-99
16%
Histone Deacetylase Inhibitor
16%
Mutagenesis
16%
Vorinostat
16%
Biotinylation
16%
Dipeptide
16%
Membrane Targeting
16%
Pertechnetate
16%
Pharmacology, Toxicology and Pharmaceutical Science
Radioactive Iodine
100%
Molecular Target
100%
Sodium Iodide Symporter
100%
Adaptor Protein
66%
Chloroquine
33%
Differentiated Thyroid Cancer
33%
Messenger RNA
16%
Recurrent Disease
16%
Disease Free Survival
16%
Mutagenesis
16%
Histone Deacetylase Inhibitor
16%
Thyroid Cancer
16%
Bagg Albino Mouse
16%
Technetium 99m
16%
Vorinostat
16%
Membrane Targeting
16%
Dipeptide
16%
Pertechnetate
16%